Insider Transactions in Q1 2025 at Century Therapeutics, Inc. (IPSC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2025
|
Brent Pfeiffenberger President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
521,500
+23.35%
|
-
|
|
Mar 11
2025
|
Chad Cowan Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+7.81%
|
-
|
|
Mar 11
2025
|
Morgan Conn Chief Finanical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+19.67%
|
-
|
|
Mar 11
2025
|
Douglas Carr SVP Finance & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
95,625
+18.87%
|
-
|
|
Mar 11
2025
|
Adrienne Farid Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+32.28%
|
-
|
|
Mar 11
2025
|
Gregory Russotti Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+23.41%
|
-
|
|
Mar 10
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
2,235
-0.19%
|
$0
$0.62 P/Share
|
|
Mar 10
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
1,240
-0.39%
|
$0
$0.62 P/Share
|
|
Mar 10
2025
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,359
-1.76%
|
$0
$0.62 P/Share
|
|
Mar 10
2025
|
Gregory Russotti Officer |
SELL
Open market or private sale
|
Direct |
2,360
-0.86%
|
$0
$0.62 P/Share
|
|
Feb 18
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
34,712
-2.83%
|
$0
$0.78 P/Share
|
|
Feb 03
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
351
-0.11%
|
$0
$0.78 P/Share
|
|
Feb 03
2025
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,054
-0.78%
|
$0
$0.78 P/Share
|